Candida auris: the fungal threat reshaping clinical diagnostics

An emerging pathogen with global impact Candida auris, recently reclassified as Candidozyma auris, has become one of the most concerning fungal pathogens in healthcare environments. Since its...

Over 25 million VirClia® tests worldwide

VirClia® reaches a new global milestone with over 25 million tests performed worldwide, reinforcing Vircell’s commitment to reliability, precision, and innovation in laboratory automation. A milestone...

Vircell participates in the MMTN Indonesia Workshop 2025 to strengthen collaboration in medical mycology

Vircell took part in the Medical Mycology Training Network (MMTN) Indonesia Workshop 2025, held in Manado, Indonesia. The event, organized with the Indonesian Society for Human and Animal Mycology...

IV SAMICEI CONGRESS

This year, Vircell Spain sponsors the exclusive symposium Diagnostic Innovations in Mycobacterial Diagnosis at the IV SAMICEI Congress which will be held in Granada on November 13, 14, and 15. We look...